91.47
-0.11 (-0.12%)
Penutupan Terdahulu | 91.58 |
Buka | 91.53 |
Jumlah Dagangan | 585,515 |
Purata Dagangan (3B) | 1,067,432 |
Modal Pasaran | 6,359,616,512 |
Harga / Pendapatan (P/E TTM) | 15.19 |
Harga / Pendapatan (P/E Ke hadapan) | 14.18 |
Harga / Jualan (P/S) | 4.75 |
Harga / Buku (P/B) | 6.42 |
Julat 52 Minggu | |
Tarikh Pendapatan | 20 Feb 2025 - 24 Feb 2025 |
Margin Keuntungan | 20.37% |
Margin Operasi (TTM) | 28.23% |
EPS Cair (TTM) | 4.36 |
Pertumbuhan Hasil Suku Tahunan (YOY) | 10.50% |
Pertumbuhan Pendapatan Suku Tahunan (YOY) | -0.70% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 57.10% |
Nisbah Semasa (MRQ) | 5.52 |
Aliran Tunai Operasi (OCF TTM) | 544.75 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | 290.56 M |
Pulangan Atas Aset (ROA TTM) | 15.35% |
Pulangan Atas Ekuiti (ROE TTM) | 32.82% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
Stok | Lantheus Holdings, Inc. | Menurun | Menaik |
AISkor Stockmoo
Konsensus Penganalisis | 1.0 |
Aktiviti Orang Dalam | 0.0 |
Volatiliti Harga | 2.0 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -0.5 |
Purata | 0.50 |
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc. |
|
Sektor | Healthcare |
Industri | Drug Manufacturers - Specialty & Generic |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 2.29% |
% Dimiliki oleh Institusi | 112.17% |
Julat 52 Minggu | ||
Julat Harga Sasaran | ||
Tinggi | 122.00 (B. Riley Securities, 33.38%) | Beli |
Median | 119.50 (30.64%) | |
Rendah | 117.00 (Truist Securities, 27.91%) | Beli |
Purata | 119.50 (30.64%) | |
Jumlah | 2 Beli | |
Harga Purata @ Panggilan | 89.08 |
Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
---|---|---|---|---|
Truist Securities | 08 May 2025 | 117.00 (27.91%) | Beli | 80.44 |
B. Riley Securities | 21 Mar 2025 | 122.00 (33.38%) | Beli | 97.71 |
Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
---|---|---|---|---|
BAYLOR-HENRY MINNIE | 78.81 | - | 2,537 | 199,941 |
BER GERARD | 78.81 | - | 2,537 | 199,941 |
EASTLAND JULIA MARIE | 78.81 | - | 2,537 | 199,941 |
HEINO MARY ANNE | 78.81 | - | 2,537 | 199,941 |
LENO SAM R | 78.81 | - | 2,537 | 199,941 |
MAEUSLI HEINZ CHRISTOPH | 78.81 | - | 2,537 | 199,941 |
MCHUGH JULIE | 78.81 | - | 2,537 | 199,941 |
MORROW PHUONG KHANH | 78.81 | - | 2,537 | 199,941 |
PRUDEN GARY J | 79.30 | 79.78 | 2,537 | 199,941 |
THRALL JAMES H | 78.81 | - | 2,537 | 199,941 |
Jumlah Keseluruhan Kuantiti Bersih | 25,370 | |||
Jumlah Keseluruhan Nilai Bersih ($) | 1,999,410 | |||
Purata Pembelian Keseluruhan ($) | 78.90 | |||
Purata Jualan Keseluruhan ($) | 79.78 | |||
Julat Insider ($) |
Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
---|---|---|---|---|---|---|
PRUDEN GARY J | Pengarah | 15 May 2025 | Dibuang (-) | 2,635 | 79.78 | 210,220 |
PRUDEN GARY J | Pengarah | 15 May 2025 | Diperolehi (+) | 2,635 | 79.78 | 210,220 |
BER GERARD | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
BAYLOR-HENRY MINNIE | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
HEINO MARY ANNE | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
EASTLAND JULIA MARIE | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
LENO SAM R | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
MAEUSLI HEINZ CHRISTOPH | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
MCHUGH JULIE | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
MORROW PHUONG KHANH | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
PRUDEN GARY J | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
THRALL JAMES H | Pengarah | 14 May 2025 | Diperolehi (+) | 2,537 | 78.81 | 199,941 |
Papar semua |
Tarikh | Jenis | Butiran |
---|---|---|
07 May 2025 | Pengumuman | Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update |
06 May 2025 | Pengumuman | Lantheus Announces Sale of SPECT Business to SHINE Technologies |
30 Apr 2025 | Pengumuman | Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies |
23 Apr 2025 | Pengumuman | Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time |
01 Apr 2025 | Pengumuman | Lantheus Completes Acquisition of Evergreen Theragnostics |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |